Guggenheim Capital’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-58,530
| Closed | -$353K | – | 2086 |
|
|
2019
Q4 | $353K | Buy |
+58,530
| New | +$339K | ﹤0.01% | 1755 |
|
|
2017
Q2 | – | Sell |
-11,987
| Closed | -$50K | – | 2891 |
|
|
2017
Q1 | $50K | Sell |
11,987
-3,538
| -23% | -$14.7K | ﹤0.01% | 2735 |
|
|
2016
Q4 | $64K | Sell |
15,525
-278,317
| -95% | -$1.48M | ﹤0.01% | 2792 |
|
|
2016
Q3 | $2.38M | Buy |
293,842
+15,621
| +6% | +$133K | 0.01% | 1506 |
|
|
2016
Q2 | $2.17M | Sell |
278,221
-50,820
| -15% | -$436K | 0.01% | 1511 |
|
|
2016
Q1 | $2.54M | Sell |
329,041
-86,798
| -21% | -$636K | 0.01% | 1416 |
|
|
2015
Q4 | $4.49M | Sell |
415,839
-218,159
| -34% | -$1.98M | 0.01% | 1066 |
|
|
2015
Q3 | $4.38M | Buy |
633,998
+290,066
| +84% | +$2.36M | 0.01% | 1113 |
|
|
2015
Q2 | $3.05M | Buy |
343,932
+274,090
| +392% | +$2.59M | 0.01% | 1446 |
|
|
2015
Q1 | $688K | Sell |
69,842
-263,239
| -79% | -$3.29M | ﹤0.01% | 2413 |
|
|
2014
Q4 | $4.08M | Buy |
333,081
+76,445
| +30% | +$934K | 0.01% | 1234 |
|
|
2014
Q3 | $2.56M | Buy |
+256,636
| New | +$2.38M | 0.01% | 1592 |
|
|
2014
Q2 | – | Sell |
-10,015
| Closed | -$33K | – | 3340 |
|
|
2014
Q1 | $33K | Sell |
10,015
-1,222
| -11% | -$4.28K | ﹤0.01% | 3180 |
|
|
2013
Q4 | $37K | Sell |
11,237
-358,576
| -97% | -$1.04M | ﹤0.01% | 3085 |
|
|
2013
Q3 | $1.12M | Sell |
369,813
-129,591
| -26% | -$888K | ﹤0.01% | 2034 |
|
|
2013
Q2 | $4.08M | Buy |
+499,404
| New | +$3.81M | 0.02% | 1153 |
|